Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects
Clinical trial NCT03594890 · COMPLETED
Trial details
- NCT number
- NCT03594890
- Sponsor
- Osivax
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2019-08-07
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.